research

The Total Cost Burden of the Autoimmune Epidemic

The Problem: We Don’t Really Know! The problem with estimating the total cost burden of the autoimmune disease (AIID) epidemic is that we really don’t know! A May 2022 NIH report validates our long-held belief that missing and inconsistent data for autoimmune diseases (AIIDs) are at the root of the

Read More »

The NIH Report on Autoimmune Disease, Part 2: Enhancing Research

NIH Report Shows Why The AIID Epidemic is Invisible An NIH research report on autoimmune disease, published May, 2022, explains why, despite affecting more Americans than cancer, autoimmune and immunoinflammatory diseases (AIIDs) remain an invisible epidemic. Autoimmunity is an orphaned research field of patchwork studies of some 80-150 individual diseases.

Read More »

Autoimmune Incidence & Prevalence: Why don’t we have good data on AIIDs? 

Since 2010, we have sought autoimmune disease (AIID) incidence and prevalence data. Despite efforts by independent organizations like AARDA/AA, AIR and many single disease groups, we never found total national autoimmune statistics. NIH/CDC statistics bury AIIDs within siloed categories: Arthritis, diabetes, or by medical specialty: rheumatology, neurology, dermatology, endocrine, etc.

Read More »

Personalized Movement Therapy for Chronic Pain: A4M 27th Annual World Congress

Patients with chronic pain may know that conventional therapies such as physical therapy, can benefit them to a certain extent, but definitely have their limits. DrBonnie360 is herself a longtime chronic pain patient and has amassed a great amount of research and insight into alternative movement therapies to help manage chronic pain. Check out this article to explore her presentation on personalized movement therapy from the A4M Annual World Congress.

Read More »

DrBonnie Presents: How the Oral Microbiome Connects to Systemic Health
The Microbiome Therapeutics US Conference 2019

Rheumatoid arthiritis, cardiovascular disease, autoimmune dosorders, and Alzheimer’s dementia: what if all of these disparate diseases could be treated by targeting a single source? In fact, research shows that this is possible. The oral microbiome is the target of numerous therapeutics opportunities that DrBonnie360 delves into in her presentation at The Microbiome Therapeutics US Conference.

Read More »